Manoj Khadka: Omega-3s and Cardiovascular Outcomes in Hemodialysis
Manoj Khadka, Resident Doctor at Patan Hospital, shared a post on LinkedIn, about recent article by Charmaine E. Lok et al., published in NEJM, adding:
“Pleased to share my journal abstract presentation reviewing the PISCES trial, published in NEJM (Nov 2025), which evaluated the impact of omega-3 fatty acid (fish oil) supplementation on cardiovascular events in patients undergoing maintenance hemodialysis.
The presentation focused on the study methodology, key findings, clinical implications, and future directions regarding the role of fish oil in cardiovascular risk reduction among dialysis patients.”
Title: Fish Oil Supplementation Reduces Cardiovascular Events in Hemodialysis Patient
Authors: Charmaine E. Lok, M.D., Michael Farkouh, M.D., Brenda R. Hemmelgarn, M.D., Ph.D., Louise M. Moist, M.D., Kevan R. Polkinghorne, M.B., Ch.B., Ph.D., George Tomlinson, Ph.D., Paul Tam, M.D., Marcello Tonelli, M.D. and Jacob A. Udell, M.D., M.P.H.
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke